Chronic heart failure
125 results
1 - 100
Ivabradine as adjuvant treatment for chronic heart failure- Hawthorn extract for treating chronic heart failure
- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
- Pharmacological interventions for heart failure in people with chronic kidney disease
- Erythropoiesis‐stimulating agents for anaemia in chronic heart failure patients
- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
- Diuretics for heart failure: Cochrane systematic review
- Phosphodiesterase III inhibitors for heart failure
- Antioxidants for adults with chronic kidney disease
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- LCZ696 (sacubitril/valsartan) for patients with heart failure
- Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm
- Non‐invasive positive pressure ventilation for central sleep apnoea in adults
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Antiplatelet agents for chronic kidney disease
- Remote digital monitoring for selected chronic diseases in primary health care
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
- Potassium binders for chronic hyperkalaemia in people with chronic kidney disease
- Structured telephone support or non‐invasive telemonitoring for patients with heart failure
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Dietary interventions for adults with chronic kidney disease
- Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews
- Aldosterone antagonists for people with chronic kidney disease requiring dialysis
- Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD)
- Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
- Continuous infusion versus bolus injection of loop diuretics for acute heart failure
- Oxygen therapy for dyspnoea in adults: Cochrane systematic review
- Angiotensin receptor blockers for heart failure
- Endovascular versus open surgical repair for complicated chronic Type B aortic dissection
- Anticoagulation versus placebo for heart failure in sinus rhythm
- mHealth education interventions in heart failure
- Interleukin‐receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
- Erythropoiesis‐stimulating agents for anaemia in adults with chronic kidney disease: a network meta‐analysis
- Cardioselective beta‐blockers for reversible airway disease
- Methods of vascular occlusion for elective liver resections
- Vitamin D for the management of chronic obstructive pulmonary disease
- Hydralazine in infants with persistent hypoxemic respiratory failure: Cochrane systematic review
- Pregabalin for decreasing pancreatic pain in chronic pancreatitis: Cochrane systematic review
- Eplerenone for hypertension
- Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Blood pressure targets in adults with hypertension
- Interactive telemedicine: effects on professional practice and health care outcomes
- Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults
- Cinnamon for diabetes mellitus
- Altered dietary salt intake for preventing diabetic kidney disease and its progression
- Immunosuppressive T‐cell antibody induction for heart transplant recipients
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Phosphodiesterase 5 inhibitors for pulmonary hypertension
- Water for preventing urinary stones
- Early referral to specialist nephrology services for preventing the progression to end‐stage kidney disease
- Effect of cyclosporine on blood pressure: Cochrane systematic review
- Interventions for weight loss in people with chronic kidney disease who are overweight or obese
- Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease
- Guanylate cyclase stimulators for pulmonary hypertension
- Personalised care planning for adults with chronic or long‐term health conditions
- Transmyocardial laser revascularization versus medical therapy for refractory angina: Cochrane systematic review
- Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications
- Automated telephone communication systems for preventive healthcare and management of long-term conditions: Cochrane systematic review
- Education programmes for people with chronic kidney disease and diabetes
- Trypanocidal drugs for late‐stage, symptomatic Chagas disease (Trypanosoma cruzi infection)